{
    "organizations": [],
    "uuid": "67be6be3571f9dfb55a0422cb6c6411bc2b1c0ec",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-moberg-pharma-us-patent-granted-fo/brief-moberg-pharma-u-s-patent-granted-for-bupi-idUSFWN1S902M",
    "ord_in_thread": 0,
    "title": "BRIEF-Moberg Pharma: U.S. Patent Granted For BUPI",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2 (Reuters) - Moberg Pharma AB (publ):\n* U.S. PATENT GRANTED FOR BUPI * MOBERG PHARMA ESTIMATES THAT PRODUCT HAS A SALES POTENTIAL AMOUNTING TO USD 100-200 MILLION ANNUALLY Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-05-02T14:33:00.000+03:00",
    "crawled": "2018-05-03T11:59:10.019+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "moberg",
        "pharma",
        "ab",
        "publ",
        "patent",
        "granted",
        "bupi",
        "moberg",
        "pharma",
        "estimate",
        "product",
        "sale",
        "potential",
        "amounting",
        "usd",
        "million",
        "annually",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}